Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 31, 2016
Pink Bikini and Shorts on the Beach Weight Supplements Recalled
Diclofenac is a non-steroid anti-inflammatory drug (NSAID), which can increase the risk of cardiovascular events and gastrointestinal damage, such as bleeding, ulceration, and fatal perforation of the stomach.
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."
Recalled Pink Bikini and Shorts on the Beach are packaged in clear bottles in multiple color capsules the expiration date of 7/30/2017. They were distributed nationwide through the company's website, PinkBikini.BigCartel.com, and retail store, "Waisted With Lucy". (Lucy's Weight Loss System issued an earlier recall of Pink Bikini white powder capsules in December 2015.)
Consumers who have purchased these supplements should not use them, and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
For more about this recall, use the link below.